3 recruiting, 2 active not recruiting, 1 completed, 1 terminated. 5 Phase 2, 1 Early Phase 1, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 2, Active not recruiting 1, Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Not applicable | 1 | Active not recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Iodine-124: new trials by email Literature Review of Iodine-124 trials Research Report on Iodine-124
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer Iodine-124, Positron Emission Tomography (PET)/Computerized tomography (CT) - Thyroid Cancer | Phase 2 | Recruiting | Thomas Hope | 62 | 2025-12-04 | 2026-06-18 |
| Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01) - Systemic Amyloidosis | Phase 2 | Completed | University of Tennessee Graduate School of Medicine | 19 | 2022-12-07 | 2026-09-02 |
| The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer Thyrogen, I-131, I-124 - Thyroid Cancer | Phase 2 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 30 | 2019-07-29 | 2026-09-09 |
| Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma PET/CT Scan, Iodine-124 - Thyroid Carcinoma, Metastatic Thyroid Carcinoma | Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 75 | 2018-08-21 | 2026-09-10 |
| I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer Radioiodine I-131, I-124 - Differentiated Thyroid Carcinoma | Not applicable | Active not recruiting | University of Wuerzburg | 340 | 2015-05-01 | 2026-10-09 |
| Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer Computed Tomography, Iodine I 124, Iodine I-131 - Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 34 | 2014-08-14 | 2026-08-28 |
| 124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors. MIBG label with I123 or I124, SPECT imaging - Parkinson Disease, Neuroendocrine Tumors | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 40 | 2013-08-01 | 2013-08-29 |
| Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT Iodine-124, PET/CT with Iodine-124 - Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Early Phase 1 | Terminated | Stanford University | 7 | 2008-02-01 | 2017-10-11 |
| Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA Iodine-124, Iodine-123, F-18 FDG - Thyroid Cancer | Withdrawn | Stanford University | 2007-05-01 | 2022-06-21 |
Thyroid Neoplasms (5) · Adenocarcinoma, Follicular (1) · Breast Neoplasms (1) · Immunoglobulin Light-chain Amyloidosis (1) · Neoplasm Metastasis (1) · Neuroendocrine Tumors (1) · Parkinson Disease (1) · Thyroid Cancer, Papillary (1)
Stanford University (2) · Memorial Sloan Kettering Cancer Center (1) · National Cancer Institute (NCI) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Tel-Aviv Sourasky Medical Center (1) · Thomas Hope (1) · University of Tennessee Graduate School of Medicine (1) · University of Wuerzburg (1)
United States (6) · Germany (1) · Israel (1)
Alan L Ho (1) · Andreas Buck, MD, Prof. (1) · Andrei Iagaru (1) · Einat Even Sapir, PhD, MD (1) · Iain Ross McDougall (1) · Irene L. Wapnir (1) · Joanna Klubo-Gwiezdzinska, M.D. (1) · Ken Herrmann, MD, Prof. (1) · Ravinder Grewal, MD (1) · Thomas Hope, MD (1)
P30CA008748 (1), P50CA172012 (1), R01CA184724 (1)